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Abstract
Forced expiratory volume in one second strongly predicts mortality from cardiovascular disease.
FEV1 has been associated with aortic stiffness a strong independent predictor of cardiovascular
mortality. However, the anatomical site and possible mechanisms linking aortic stiffness and lung
function are unknown. We therefore examined if FEV1 and CT percent emphysema were
associated with calcification of the abdominal aorta or reduced distensibility of the proximal
thoracic aorta.
The Multi-Ethnic Study of Atherosclerosis (MESA) measured aortic calcification on cardiac and
abdominal CT scans and proximal aortic distensibility using magnetic resonance among
participants aged 45–84 years without clinical cardiovascular disease. Spirometry was measured
following ATS/ERS guidelines and percent emphysema was measured in the lung fields of cardiac
CT scans. Multivariate analyses adjusted for age, sex, race/ethnicity and cardiovascular risk
factors.
Of 1,917 participants with aortic distensibility measures, 13% were current and 38% were former
smokers. Eighteen percent had airflow limitation without asthma. FEV1 was associated with the
extent of distal aortic calcification (0.76; 95%CI 0.60–0.97, p=0.02) but not proximal aortic
calcification or proximal aortic distensibility (−0.04 mmHg−1; 95%CI −0.16–0.09 mmHg−1,
p=0.60). Percent emphysema was associated with neither measure.
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FEV1 was associated with severity of distal aortic calcification where it was present independently
of smoking and other cardiovascular risk factors but not with distensibility or calcification of the
proximal aorta.
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INTRODUCTION
Forced expiratory volume in one second strongly predicts mortality from cardiovascular
disease in general population samples. (1) In addition, cardiovascular disease is an important
cause of death in patients with chronic obstructive pulmonary disease (COPD) (2).
Pulse wave velocity (PWV), which predicts cardiovascular mortality, (3) is measured as the
rate of transmission of a pressure wave across the aorta and femoral artery (4), and is thus an
indirect measure of regional aortic stiffness. PWV is associated with FEV1 in men, (5, 6)
and is higher in COPD patients than in controls matched on age, sex and smoking. (7, 8)
However, although regional aortic stiffness has been associated with pulmonary function we
are not aware of any study examining the association between pulmonary function and local
arterial stiffness within the aorta.
The highly elastic proximal aorta is rich in elastin and may therefore be susceptible to elastin
degradation and abnormal collagen remodelling, whereas calcification of the more distal
muscular aorta may arise from systemic inflammation and oxidative stress. As such
proximal aortic pathology might implicate a common susceptibility in the connective tissue
of artery and lung whereas distal aortic pathology might implicate systemic inflammation
which is associated with airflow limitation. (9, 10) Abdominal aortic calcification is itself a
strong predictor of cardiovascular mortality (11, 12) yet the relationship of FEV1 to aortic
calcification has not been established.
Therefore we tested the hypothesis that decrements in the FEV1 and increments in percent
emphysema on computed tomography (CT) scans are associated with reduced distensibility
of the ascending aorta on magnetic resonance (MR) and calcification of the vasculature from
the ascending aorta to the iliac arteries. (13)
METHODS
The Multi-Ethnic Study of Atherosclerosis (MESA) is a multicenter prospective cohort
study designed to investigate sub-clinical cardiovascular disease in individuals without
clinical cardiovascular disease. (14) In 2000–2002, MESA recruited 6,814 men and women
ages 45–84 years old from six U.S. communities: Forsyth County, NC; Northern Manhattan
and the Bronx, NY; Baltimore City and Baltimore County, MD; St. Paul, MN; Chicago, IL;
and Los Angeles, CA. MESA participants were European-American white, African-
American, Hispanic, or Asian-American (mostly of Chinese origin). Exclusion criteria were
clinical cardiovascular disease, weight > 300 lbs, pregnancy or impediment to long-term
participation. (14) MESA protocols and all studies described herein have been approved by
the Institutional Review Boards of all collaborating institutions.
The MESA Lung Study enrolled 3,965 MESA participants of 4,483 sampled randomly from
among those who consented to genetic analyses, underwent baseline measures of endothelial
function, and attended an examination during the MESA-Lung recruitment period in 2004–
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2006 (99%, 89%, and 91% of the MESA cohort, respectively). Chinese-Americans were
over sampled to improve the precision of estimates for this group. For the current cross-
sectional analysis related to obstructive lung disease, we excluded participants with
restrictive spirometry, defined as a forced vital capacity (FVC) less than the lower limit of
normal (LLN) (15) with a forced expiratory volume in one second (FEV1)/FVC ratio above
0.70.
Aortic Calcification
CT scans of the abdomen were acquired on multidetector (MD) and electron beam (EBT)
scans in 2002 and 2005 in a randomly selected subset of the cohort. CT images were
analyzed centrally using a standard protocol by the MESA CT Reading Center. Calcification
in the wall of the distal abdominal aorta in an 8 cm in length segment proximal to the aortic
bifurcation was measured. For consistency with previous MESA studies, calcification was
identified as a plaque of ≥1mm2 with a density of ≥130 Hounsfield units (Hu) and quantified
using the Agatston scoring method. (13) Calcification in the proximal abdominal aorta and
each iliac artery was scored similarly.
Similar methods were used on cardiac CT scans in 2000–02 (16) to measure ascending
aortic calcification and descending thoracic aortic calcification. Calcification was identified
as plaque of ≥4.6 mm3 and ≥5.5 mm3 on EBT and MDCT respectively as previously
described. (17)
Proximal Aortic Distensibility
Consenting participants underwent a cardiac MR scan in 2000–2002. The protocol, its
reliability and characteristics of MESA participants with and without MR measures have
been previously described. (18) All imaging was performed on 1.5 T magnets with a 4-
element phased-array surface coil positioned anteriorly and posteriorly, electrocardiographic
gating, and brachial artery blood pressure monitoring.
Aortic cross sectional area at the level of the right pulmonary artery during systole and
diastole were calculated in a subset of the cohort using an automated contour routine using
the software FLOW (Medis, Netherlands). Brachial blood pressure was measured with the
participant supine in the MRI scanner before and after the scan. Proximal aortic
distensibility, a well-validated measure of proximal aortic stiffness, (18, 4) was calculated as
1000 × (maximum area – minimum area) / (minimum area × brachial pulse pressure). (18)
Left ventricular stroke volume was calculated as previously described. (19)
Spirometry
Spirometry was conducted in 2004–2006 in accordance with the American Thoracic
Society/European Respiratory Society guidelines. (20) All participants performed at least
three acceptable manoeuvres. Tests were conducted using a dry-rolling-sealed spirometer
and software that performed automated quality checks as manoeuvres were performed
(Occupational Marketing, Inc., Houston, TX). All spirometry exams were reviewed by one
investigator and each test was graded for quality. (21) Participants with no acceptable curves
were excluded from spirometry analyses.
CT Percent Emphysema
Quantitative measures of emphysema on CT scan were performed on the lung fields of full-
inspiration cardiac CT scans acquired in 2000–2002, which imaged approximately 70% of
the lung volume from the carina to the lung bases. (22) Two scans were performed on each
participant; the scan with the higher air volume was used for analyses except in cases of
discordant scan quality, in which case the higher quality scan was used.
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Image attenuation was assessed using modified Pulmonary Analysis Software Suite (23) at a
single reading centre by trained readers without knowledge of other participant information.
CT percent emphysema low attenuation area was defined as the percentage of the total
voxels in the lung which fell below −910 HU. The ICC on blinded re-reads was 0.94.
Attenuation of inside and outside air was measured, and CT percent emphysema measures
corrected for each were obtained for use in sensitivity analyses.
Percent emphysema measures from the carina to lung base are highly correlated (r=0.99)
with full-lung measures on the same full-lung scans in smokers. Emphysema measures from
MESA cardiac scans correlated with full-lung scans (e.g., r=0.93 on MD-CT scanners). (22)
Potential Confounders
Age, gender, race/ethnicity, educational attainment, and medical history were self-reported.
Current smoking was defined as self-report of a cigarette in the last 30 days or urinary
cotinine level at the time of CT exam of greater than 100 ng/ml (Immulite 2000 Nicotine
Metabolite Assay; Diagnostic Products Corp., Los Angeles, CA).
Asthma was defined as self-report of physician-diagnosed asthma before age 45 years in
order to avoid including participants with COPD in the definition of asthma, as misdiagnosis
is common and differential by gender. (24)
Height, weight and resting blood pressure were measured using standard techniques, the
latter with the Dinamap Monitor PRO 100 (Critikon, Tampa, FL) automated oscillometric
device. Hypertension was defined as a systolic blood pressure > 140 mm Hg, a diastolic
blood pressure > 90 mm Hg, or currently taking medications for BP control. (25)
Glucose and lipids were measured after a 12-h fast. The presence of diabetes mellitus was
based on self-reported physician diagnosis, use of insulin and/or oral hypoglycaemic agent,
or a fasting glucose value >126 mg/dL measured by rate reflectance spectrophotometry
(Johnson & Johnson Clinical Diagnostics, Inc., Rochester, NY). Total cholesterol was
measured using a cholesterol oxidase method (Roche Diagnostics), as was HDL after
precipitation of non-HDL cholesterol with magnesium/dextran, triglycerides using
Triglyceride GB reagent (Roche Diagnostics). LDL-cholesterol was calculated in plasma
specimens having a triglyceride value <400 mg/dl using the formula of Friedewald et al.
Statistical Analysis
Demographics and medical characteristics were tabulated by respiratory condition/
spirometric criteria. Among individuals without self-reported asthma before age 45,
participants with normal lung function and with various degrees of severity of severity of
airflow obstruction were compared. Multiple linear regression of proximal aortic
distensibility on lung density and lung function was performed. Analyses adjusted for study
site, age, race/ethnicity, gender, height, body mass index, cigarette smoking status, pack
years, diabetes, hypertension, educational attainment (as a measure of socioeconomic
status), serum low density lipoprotein, high density lipoprotein, and glucose concentration,
antihypertensive therapy, and lipid lowering therapy.
We employed relative risk regression with robust standard errors (log-link and Poisson error
distribution) to estimate associations between relevant variables and the presence of
detectable calcification. Among participants with detectable calcification we modelled the
log-transformed magnitude of distal abdominal aortic calcification using linear regression.
The exponentiated coefficients are presented, and may be interpreted as multiplicative (i.e.
ratio) change in average distal abdominal aortic calcification. (26) Formal adjustments for
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multiple comparisons were not performed, (27) but rather the results of all analyses are
presented.
Sensitivity analyses were performed using emphysema measures corrected for both outside
and inside air. Interactions were tested with multiplicative terms in regression models.
Analyses were performed with SPSS version 14 (Chicago, Illinois, USA) and R 2.8.1 (R
Foundation, Vienna, Austria). P-values were two-tailed with p < 0.05 considered statistically
significant.
RESULTS
Of the participants in the MESA Lung Study with valid spirometry measures and without
restrictive lung disease, 1,917 had proximal aortic distensibility MR measures and 1,312 had
distal abdominal aortic CT measures (Figure 1). Those with proximal aortic distensibility
MR measures were younger and less likely to have hypertension and diabetes but were
otherwise similar to those without such measures. Participants with distal abdominal aortic
calcification measures were very similar to those without.
Participants with proximal aortic distensibility measures were on average 60 years old and
47.1% were male. Nine percent reported a diagnosis of asthma before age 45 years, and 148
(7.7%) of the remaining participants had airflow obstruction on spirometry. Those with
airflow obstruction were older, more likely to be male and to have hypertension, diabetes,
chronic bronchitis and a history of smoking (Table 1). Similar associations were found for
the sub-group with distal abdominal aortic calcification measures (Table 2).
Pulmonary Function in Relation to Aortic Calcification
Of the 1,312 participants who had distal abdominal aortic calcification measured, 903
(68.8%) had detectable calcification. Although the presence of distal abdominal aortic
calcification was not associated with FEV1 (RR 0.92; 95% CI 0.80 to 1.07; p = 0.28) lower
FEV1 was associated with a greater multiplicative (ratio) increment in the extent of distal
abdominal aortic calcification after adjusting for study centre, age, sex, race/ethnicity,
height, and BMI (FEV1, 0.57, 95% CI, 0.45 to 0.72, p<0.001). The strength of the
association was attenuated but still evident after additional adjustment for cigarette smoking
status, pack years, diabetes, hypertension, educational attainment, serum low density
lipoprotein, high density lipoprotein, and glucose concentration, antihypertensive therapy,
and lipid lowering therapy (0.76, 95% CI 0.60 to 0.97, p=0.02).
The FEV1/FVC ratio was also associated with the extent of distal abdominal aortic
calcification after minimal adjustment, and similar trends were evident in the full model,
although the associations were no longer statistically significant (Table 3).
Similar associations between FEV1 and vascular calcification were found in the more distal
iliac arteries (Figure 2). In contrast, there was no evidence for an association between FEV1
and ascending aortic calcification or descending thoracic aortic calcification (Figure 2). A
similar pattern was found for the FEV1/FVC ratio, but not for the FVC (data not shown).
Pulmonary Function in Relation to Proximal Aortic Distensibility
Similar to findings for thoracic aortic calcification, proximal aortic distensibility was not
associated with pulmonary function after adjusting for study center, age, sex, race/ethnicity,
height, and BMI (−0.02 mmHg−1, 95% CI −0.15 to 0.11 mmHg−1, p =0.75) or after
adjusting for the additional covariates as described above (−0.04, 95% CI −0.16 to 0.09, p =
0.60). Results for the FEV1/FVC ratio were similarly null (Table 3).
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CT Percent Emphysema in Relation to Proximal Aortic Distensibility, and Distal Abdominal
Aortic Calcification
There was no evidence to suggest that CT percent emphysema was associated with
abdominal aortic calcification (1.05, 95% CI 0.72 to 2.06, p=0.47) or aortic distensibility
(0.03 mmHg−1, 95% CI −0.02 to 0.09 mmHg−1, p = 0.19) in the full multivariate models
adjusted for study site, age, race/ethnicity, gender, height, body mass index, cigarette
smoking status, pack years, diabetes, hypertension, educational attainment, serum low
density lipoprotein, high density lipoprotein, and glucose concentration, antihypertensive
therapy, lipid lowering therapy and scanner type and protocol.
Airflow Obstruction on Spirometry in Relation to Proximal Aortic Distensibility, and Distal
abdominal aortic calcification
Similar results for distal abdominal aortic calcification were obtained when participants
were compared by respiratory condition/spirometric criteria. Compared to participants with
normal lung function without self-reported asthma, distal abdominal aortic calcification was
higher for participants with moderate airflow obstruction (1.24, 95% CI 0.87 to 1.79), and
higher still in those with severe airflow obstruction (1.31, 95% CI 0.55 to 3.13).
Reduced proximal aortic distensibility was not evident in participants with moderate or
severe airflow obstruction, indeed compared to participants with normal lung function,
proximal aortic distensibility was higher for those with moderate airflow obstruction (0.24
mmHg−1, 95% CI 0.02 to 0.46 mmHg−1) and severe airflow obstruction (0.09 mmHg−1,
95% CI −0.44 to 0.62 mmHg−1).
Sensitivity Analyses
Sensitivity analyses limited to participants who had smoked greater than 10, 20 and 50 pack-
years produced similar results. Exclusion of participants with asthma diagnosed before the
age of 45 did not affect the results; neither did exclusion of participants with any diagnosis
of asthma, nor use of CT percent emphysema measures corrected for outside air or airways
air, or use of the 15th percentile point. Additional adjustment for self-reported use of
bronchodilators, steroids, or methylxanthines and measures of inflammation (serum
interleukin-6 and C-reactive protein levels) had little impact on the results.
There was no evidence for effect modification on an additive scale by gender, race/ethnicity,
smoking status, study site, CT scanner type or severity of airflow obstruction on spirometry,
nor any evidence of statistically significant departures from linearity for any of the main
relationships (data not shown).
DISCUSSION
In this unique and large study, an obstructive pattern of spirometry was associated with
greater extent of calcification in the distal aorta. In contrast, obstructive spirometry was
associated neither with proximal aortic calcification nor with proximal aortic distensibility
on MRI. Furthermore, there was a graded increase in the magnitude of the association
between pulmonary function and the extent of calcification from the proximal thoracic to
distal abdominal aorta.
Previous population-based studies that have examined associations between pulmonary
function and PWV are limited to two European studies of 194 and 827 middle aged men, (6)
in which associations were found, and one negative study in 678 healthy Japanese-
Americans. (28) Aortic PWV has also previously been found to be higher in patients with
COPD than controls matched on age, sex and smoking. (7, 8)
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Abdominal aortic calcification is associated with PWV. (29, 30) and, like PWV, is a
cardiovascular risk factor (11, 12). Therefore, it is of some interest that calcification is
related to pulmonary function. Our study adds to the literature by demonstrating that
pathological changes in the distal aorta are more likely to explain the association between
pulmonary function and aortic stiffness than changes in the proximal aorta.
These findings may generalise to patients with COPD as, despite loss of statistical power as
a consequence of categorisation, similar results for abdominal aortic calcification and
proximal aortic distensibility were obtained when participants were compared by respiratory
condition, as defined spirometrically.
The mechanisms underlying the distal aortic calcification are unknown, but inflammatory
mediators such as TNF-alpha, high sensitivity C-reactive protein and oxidised lipids, which
are increased in COPD, (9, 31) could mediate an association between impaired lung function
and vascular calcification which occurs both in the intima in atheromatous plaques, and in
the medial elastic laminae. C-reactive protein has been implicated in atheroma formation.
(32) TNF-alpha causes smooth muscle cells to undergo osteoblastic differentiation and
mineralisation thereby promoting calcification. (33) Oxidised lipids also promote smooth
muscle cell osteoblastic differentiation, but inhibit this process in bone-derived
preosteoblasts (34) which is of particular interest since osteoporosis is inversely associated
with arterial stiffness in COPD. (7)
We did not find any attenuation in the association between FEV1 and abdominal aortic
calcification after adjusting for C-reactive protein and interleukin-6. However, both
measures show considerable variability and were only measured at a single time point, while
measures of TNF-alpha and oxidised lipids were not available for the majority of
participants.
Comprehensive assessments meant that we were able to adjust for a wide range of potential
confounders including cigarette smoke exposure and cardiovascular risk factors, although
we did not measure arterial oxygen tension. Nevertheless, acute changes in oxygenation
appear unlikely to affect vascular calcification.
Spirometry was performed without administering a bronchodilator, and as such a proportion
of participants with airflow obstruction may have had asthma. However, excluding
participants who had ever had a diagnosis of asthma did not affect our findings, nor did
confining the analysis to those participants with a 50 or greater pack year smoking history.
Moreover, participants with asthma had higher aortic distensibity and lower calcification.
MESA CT measures of emphysema were obtained from the lung fields of cardiac CT scans
and therefore visualization of the lung apices was limited. Nonetheless, the CT percent
emphysema measures were highly reproducible and validated. (22)
Lung function was assessed approximately 4 years after the other measures. However, the
expected mean change in FEV1 over a period of 4 years in a population-based study such as
MESA is small, (35) and in a previous population-based study aortic PWV was found to be
associated with FEV1 measured approximately 10 years prior as well as FEV1 measured
contemporaneously, suggesting that relationships between pulmonary function and aortic
stiffness are reasonably consistent over time. (6)
MESA excluded participants with known cardiovascular disease at baseline. However, this
is likely to lead to an underestimation of the strength of the association between aortic
calcification and FEV1.
McAllister et al. Page 7
COPD. Author manuscript; available in PMC 2013 April 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Power was limited for participants with severe airflow obstruction, and caution is required in
extrapolating these findings to this group. Nevertheless, there was no evidence for any
departure from linearity across the range of lung function, and results comparing participants
with moderate and severe airflow obstruction on spirometry were consistent with those
obtained measuring pulmonary function in the full cohort.
CONCLUSION
In conclusion, FEV1 was associated with distal aortic calcification where it was present
independently of smoking and other cardiovascular risk factors but not with distensibility or
calcification of the proximal aorta. Therefore pathological changes in the distal aorta are
more likely to explain the association between pulmonary function and aortic stiffness than
changes in the proximal aorta.
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Figure 1.
Inclusion and exclusion criteria for cross-sectional analysis
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Figure 2.
Multivariate associations of the forced expiratory volume in one second with presence and
multiplicative change in aortic calcification from the proximal ascending thoracic aorta to
the distal abdominal aorta and iliac arteries
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Table 3
Multivariate Analysis – Distal abdominal aortic calcification and Proximal Aortic Distensibility in Relation to
FEV1, FVC, the FEV1/FVC ratio, and CT Percent Emphysema
Exposure (units) Estimated multiplicative (ratio) change in
distal abdominal aortic calcification
(95% CI), n=903
P Value for
Trend
Absolute change in proximal aortic
distensibility (mmHg−1), (95% CI),
n=1917
P value
FEV1 (litres)
Model 1 0.57 (0.45 to 0.72) <0.001 −0.02 (−0.15 to 0.11) 0.75
Model 2 0.76 (0.60 to 0.97) 0.02 −0.04 (−0.16 to 0.09) 0.60
FVC (litres)
Model 1 0.72 (0.58 to 0.91) 0.006 0.02 (−0.09 to 0.13) 0.29
Model 2 0.82 (0.66 to 1.02) 0.07 0.00 (−0.88 to 0.45) 0.95
FEV1/FVC (ratio)
Model 1 0.76 (0.67 to 0.86) <0.001 −0.35 (−1.00 to 0.30) 0.30
Model 2 0.91 (0.80 to 1.04) 0.17 −0.21 (−0.88 to 0.45) 0.53
FEV1 – Forced Expiratory Volume in One Second, FVC – Forced Vital Capacity
Model 1: adjusted for study site, age, race/ethnicity, gender, height, and body mass index.
Model 2: adjusted for model 1 and cigarette smoking status, pack years, diabetes, hypertension, educational attainment, serum low density
lipoprotein, high density lipoprotein, and glucose concentration, antihypertensive therapy, and lipid lowering therapy.
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